Nicox is on track to file for approval of its NCX 470 therapy for eyesight-robbing disease glaucoma after it showed efficacy in a second pivotal trial. The positive data from the Phase 3 Denali trial ...

United States 3-Month Bond Yield Stay on top of current and historical data relating to United States 3-Month Bond Yield. The yield on a Treasury bill represents the return an investor will receive by ...

Get the latest new motorcycle news from the experts at MCN. Our dedicated news team have their ears to the ground to provide you with the key stories you need to know about in the world of new bikes.